olaparib ATM Loss, +27 more biomarkers Prostate Carcinoma Castration-resistant, +1 more state Subsequent line olaparib targeted therapy
olaparib ATM Loss, +27 more biomarkers Prostate Adenocarcinoma Castration-resistant, +1 more state Subsequent line olaparib targeted therapy
pidnarulex ATM Loss, +27 more biomarkers Breast Carcinoma, +1 more condition pidnarulex targeted therapy
Cancer Search
